Celligenics Pte. Ltd. (Singapore)

Celligenics Pte. Ltd. is a Singapore-based biotechnology company that describes itself as working to enable regenerative biologics and advance the future of regenerative science. Its core technology is the Celligenics Secretome Platform, which is built around the regenerative substances released by stem cells rather than the stem cells themselves. According to the company, these substances include growth factors, cytokines, peptides, and extracellular vesicles, collectively referred to as the secretome. Celligenics positions its approach as a way to translate regenerative science into practical applications. The advantages the company claims begin with what it calls source purity: a curated stem cell source combined with proprietary source-to-secretome technology, which is said to support a purer and more consistent profile that the company links to stronger regenerative performance. A second pillar is cell-free regeneration, meaning capturing the benefits of stem cell science without delivering living cells. Celligenics frames this as reducing safety, ethical, and regulatory complexity. Celligenics places its work in the context of an aging population, where the challenge is no longer merely extending lifespan but improving quality of life. Aging, injury, and chronic disease slow the body's natural ability to repair and recover, and the company aims to address this through its secretome-based platform. The company is headquartered in Singapore and operates under the legal name Celligenics Pte. Ltd. Its public-facing channel is the company website celligenics.com. The evidence provided does not include details on its founding, ownership, financing, executive team, or product pipeline.

Celligenics Pte. Ltd. is a Singapore biotechnology company. The supplied evidence does not include a founding date, founder names, ownership structure or a detailed corporate history. What is documented is the company's technology narrative and positioning. Celligenics presents itself as a company enabling regenerative biologics and advancing the future of regenerative science. Its central technology is the Celligenics Secretome Platform. The company explains that stem cells are known for their regenerative potential, but that much of their benefit comes from the regenerative substances they release. These substances — growth factors, cytokines, peptides and extracellular vesicles — are collectively known as the secretome. Celligenics states that it harnesses the stem cell secretome to translate regenerative science into real-world applications. The company describes two main advantages. The first is source-led purity: selected stem cell sources and proprietary source-to-secretome know-how are said to support a purer, more consistent profile, translating into stronger regenerative performance. The second is cell-free regeneration: capturing the benefits of stem cell science without live-cell delivery, which the company says reduces complexity around safety, ethics and regulation. Celligenics frames its mission in the context of ageing populations. It notes that as people live longer, the challenge is no longer only to extend life but to improve the quality of living, and that ageing, injury and chronic conditions can slow the body's natural ability to repair and recover. The company's platform is aimed at this problem space. Beyond these points, the available evidence is limited to the company's own website and a Wikidata entry identifying it as a company in Singapore. No milestones, funding rounds, partnerships, product approvals or leadership changes are documented in the supplied material.

Cell-free, source-led purity regenerative biologics platform

• Celligenics Secretome Platform

  A cell-free platform that harnesses the stem cell secretome — growth factors, cytokines, peptides and extracellular vesicles — for regenerative applications, emphasizing source-led purity and cell-free regeneration.

1. 1Celligenics | A Singapore Biotechnology Companycelligenics.com
2. 2Celligenics Pte. Ltd. (Singapore) - Wikidatawikidata.org